CANDY THORPE: Open Payments
NPI 1376080291 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 71 payments from 15 companies in 2025. Trend: 2023 $550 · 2024 $1,663 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $269 |
| Ardelyx, Inc. | 11 | $157 |
| Regeneron Healthcare Solutions, Inc. | 9 | $136 |
| Janssen Biotech, Inc. | 6 | $118 |
| Gilead Sciences, Inc. | 3 | $88 |
| PFIZER INC. | 4 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 7 | $50 |
| GENZYME CORPORATION | 2 | $44 |
Products named: RINVOQ, DUPIXENT, IBSRELA, TREMFYA, XELJANZ, XIFAXAN, REZDIFFRA, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
